Navigation Links
MedImmune Announces Phase 2 Safety Data for Anti-RSV Antibody and National RSV Surveillance Results
Date:10/4/2007

nt relative reduction in the incidence of RSV lower respiratory tract infections requiring outpatient management, a secondary endpoint.

About MedImmune

MedImmune strives to provide better medicines to patients, new medical options for physicians and rewarding careers to employees. Dedicated to advancing science and medicine to help people live better lives, the company is focused on the areas of infectious diseases, cancer and inflammatory diseases. With approximately 3,000 employees worldwide and headquarters in Maryland, MedImmune is wholly owned by AstraZeneca plc (LSE: AZN.L, NYSE: AZN). For more information, visit MedImmune's website at http://www.medimmune.com.


'/>"/>
SOURCE MedImmune, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Infinity and MedImmune Present Updated Phase I Results of IPI-504 in GIST at ASCO Annual Meeting
2. Infinity and MedImmune Announce Updated Data On Ipi-504 to be Presented At ASCO
3. MedImmune Highlights Advances in Inflammatory Disease Pipeline With Series of Data Presentations
4. MedImmune Announces Positive Clinical Results at PAS Annual Meeting From Large Prospective Trial in Prevention of Serious RSV Disease
5. Pediatric Academic Societies Annual Meeting to Feature Data Presentations Related to MedImmune Clinical Programs in Influenza, RSV and hMPV
6. Micromet Achieves Milestone in BiTE Research Collaboration with MedImmune
7. MedImmune Publishes New Data in Nature Immunology Demonstrating The Role HMGB1 May Play in Systemic Autoimmune Diseases
8. MedImmune and Micromet Publish Data on Novel Anti-Cancer BiTE Molecule
9. Micromet and MedImmune Present Data From Preclinical Study of New BiTE Molecule Targeting CEA
10. Infinity and MedImmune to Present Preclinical Data From Study of Oral Formulation of IPI-504 At AACR
11. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2008)...- Southern Research Institute,today announced that...ted,the organization to participate in the newly-f...Network (MLPCN). The MLPCN -- a collaborative,rese... Program which is,designed to benefit human health... and validate future targets for drug discovery., ...
(Date:9/4/2008)...umab to be Presented, PRINCETON, N.J., Sept. 4 /P...DX ) announced today that nine clinical abstracts ...ibody, in melanoma are scheduled to be,the subject...pean Society,for Medical Oncology (ESMO) being hel...following abstracts will include updated one-year ...
(Date:9/4/2008)...h Two Abstracts Accepted for Presentation, and...IDGEWATER, N.J., Sept. 4 /- Aegerion ...company focused on the treatment of,cardiovascular...tment of,Peter L. Garrambone, Jr. to the Company,s...ncludes more than 50 pharmaceutical,transactions e...
(Date:9/3/2008)...tCall/ -- Simcere,Pharmaceutical Group (NYSE: SCR... generic pharmaceuticals and manufacturer of the p...wn as Endostar) in China,announced the interim re...quest of the SFDA, Simcere initiated a Phase IV cl...erapeutic efficacy of Endu, a modified,version of ...
Breaking Medicine Technology:Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 2Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 3Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 4Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology 2Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology 3Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 3Workshop Helps Parents Kids Talk About Sex 23817 1Workshop Helps Parents Kids Talk About Sex 23817 2Non parental care of infants tied to unfavorable feeding practices 23813 1Non parental care of infants tied to unfavorable feeding practices 23813 2Non parental care of infants tied to unfavorable feeding practices 23813 3I Play Clean 28TM 29 and Old Spice Kick Off Campaign Challenging High School Students to Pledge Against Steroid Use 23809 1I Play Clean 28TM 29 and Old Spice Kick Off Campaign Challenging High School Students to Pledge Against Steroid Use 23809 2I Play Clean 28TM 29 and Old Spice Kick Off Campaign Challenging High School Students to Pledge Against Steroid Use 23809 3I Play Clean 28TM 29 and Old Spice Kick Off Campaign Challenging High School Students to Pledge Against Steroid Use 23809 4I Play Clean 28TM 29 and Old Spice Kick Off Campaign Challenging High School Students to Pledge Against Steroid Use 23809 5Chindex International Inc Announces CDC Contract Signing 23805 1Chindex International Inc Announces CDC Contract Signing 23805 2Chindex International Inc Announces CDC Contract Signing 23805 3Chindex International Inc Announces CDC Contract Signing 23805 4
...ter damage caused by,flooding over the weekend, FD...pcoming Antiviral Drugs Advisory Committee,meeting... for,maraviroc 300 milligram tablets. Originally s...aluation and Research Advisory Committee,Conferenc... the,meeting has been relocated to , Crown Plaza H...
...-- Sirion Therapeutics,Inc., an ophthalmic-focuse...it has received orphan drug designation from the F...al therapy,ganciclovir, for the treatment of acut...keted by Laboratoires Thea in Europe under,the bra...o,Virgan(R) for the United States from Laboratoire...
Other Medicine Technology:FDA Announces Change of Location Notice for Upcoming Advisory,Committee Meeting 2Sirion Therapeutics Receives Orphan Drug Designation for Ophthalmic,Drug to Treat Viral Eye Infection 2
(Date:9/5/2008)...G, Pa., Sept. 5 /PRNewswire-USNewswire/ -- Childre...r access to comprehensive,services to protect thei...n,in grants that were announced today by the Depar...vices for children and families, the department,be...ren,s Services Planning,initiative, ICSP, in 2004....
(Date:9/5/2008)..., Md., Sept. 5 /PRNewswire-USNewswire/ -- The Heal...day announced $39 million in grants to,increase an...centers., "These grants continue President Bush,s...whose services now reach more economically,vulnera...r before," HRSA,Administrator Elizabeth M. Duke sa...
(Date:9/5/2008)...ontrolled, but you need to know what triggers them...thDay News) -- If you are one of the 36 million Am...is nowhere in the United States that is free from ... shows. , Allergies don,t only happen in the sp...ell. In the fall, the most challenging cities to l...
(Date:9/5/2008)...N, Sept. 5 /PRNewswire-USNewswire/ -- Speaker Nanc...upport of the aims of the "Stand,Up to Cancer" tel...re is not a person in our country who has not seen...s 565,000 Americans annually, and each,year there ... must work,together to make eradicating the scourg...
Breaking Medicine News(10 mins):Health News:Pennsylvania Counties Receive Grants to Improve Services for Children 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:No Place Safe From Allergies 2
Plump Infants Getting Obese Later In Life In More Cases
...t Johns Hopkins University claims that the drug Vi...mance// in men could also reduce the effect of hor...usly thought, drugs like Viagra can in fact alter ...y when the heart is stimulated by hormones,' said ...
...osely watching the ‘Avian Flu’ that is spreading t...rmed a task force to tackle this emergency. The ta...vedi and includes secretaries of health, environme...istries. The inter-ministerial task force is to fo...
...t depression may not be the only factor-probing ad...rs might therefore need to watch out for other men... World Health Organization re-examined the occurre... in 894 cases of completed suicides among young pe...
Other Medicine News:Health News:Viagra Halves Effect Of Hormonal Stress On Heart 2Health News:Multi targeted approach required for suicide prevention in adolescents 2
Features and Benefits: 1-12channel pipette This CLS number is a new product number, created to easily match Cornings product number. If showing no availability yet, please order under the old Sigma-A
...ell plates in mind, Pipetman Ultra Multichannel is...tions: PCR* sequencing, immunology assays, series ...mond Tips from Gilson's patented Rocky Rack system...e productivity.,* PCR process is covered by US pat...
...ion, ergonomics, and value!, Comfortable feel and...andle , Finer control while pipetting with smooth,...ction with long, lever tip ejector , Completely au...ion without the need for recalibration , Easy-to-r...
Finnpipette Focus multichannel pipettes speed up repeat dispensing of reagents into microplates, with super blow-out for 0.1-10 l volumes. The improved ergonomic design of Finnpipette Focus multichan
Medicine Products: